Sartan plus Neprilysin-Hemmer senkt HbA1c stärker als ACE-Hemmer
Crossref DOI link: https://doi.org/10.1007/s15034-017-1125-z
Published Online: 2017-09-04
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fritschka, Emanuel
License valid from 2017-09-01